Publique en esta revista
Información de la revista
Vol. 54. Núm. 12.
Páginas 629-630 (Diciembre 2018)
Descargar PDF
Más opciones de artículo
Vol. 54. Núm. 12.
Páginas 629-630 (Diciembre 2018)
Scientific Letter
DOI: 10.1016/j.arbres.2018.03.004
Acceso a texto completo
Mature Cystic Teratoma of the Lung With a Somatic-Like Malignant Component in a Patient With Testicular Germ-Cell Tumor
Teratoma quístico maduro de pulmón con componente maligno de tipo somático en un paciente con un tumor testicular de células germinales
Ana Vallejo-Beníteza,
Autor para correspondencia

Corresponding author.
, Enrique Rodríguez-Zarcoa, Sofia Pereira-Gallardoa, Laura Macías-Garcíab
a Hospital Universitario Virgen Macarena, Seville, Spain
b Department of Cytology and Histology Normal and Pathological, University of Seville, Seville, Spain
Información del artículo
Texto completo
Descargar PDF
Figuras (1)
Texto completo
Dear Editor:

In urological oncology, the diagnosis of teratoma with a somatic-like malignant component refers to the presence of a malignant neoplasm, e.g. carcinoma or sarcoma, either within a teratoma of the genital tract (usually the testis) or, more commonly, in a metastasis, following initial cisplatin therapy.1 The somatic-type malignancy (STM) most widely observed in germ cell tumors (GCT) is rhabdomyosarcoma; neuroendocrine carcinoma is extremely rare.2

We report on a 40-year-old patient who had undergone surgery seven years earlier for a malignant mixed germ-cell tumor of the right testicle with pulmonary and retroperitoneal metastasis, and received cisplatin therapy. At recent check-up, CT scans revealed some enlargement of known lung lesions; blood alpha-fetoprotein levels were also slightly elevated (AFP: 9ng/ML). Since needle-biopsy findings were inconclusive, lung nodules were all excised by videothoracoscopy. Histological examination of them revealed a multicystic lesion containing solid areas. The cystic component was lined by squamous, respiratory and intestinal epithelium, a finding consistent with a mature teratoma. The solid component comprised tumor cell nests displaying peripheral pallisading, an organoid arrangement with rosette formation, focal necrosis and a high mitotic rate (6/10 HPF) (Fig. 1A). No elements characteristic of immature teratoma were observed. Immunohistochemical analysis revealed patchy focal positivity for CK7, CK20, CDX2 and SOX2 in the cylindrical epithelial cells of the cystic component (Fig. 1B and C). Solid-component cells stained positive for cytokeratin (AE1/AE3), chromogranin-A (Fig. 1D), synaptophysin, and cytoplasmic OCT4, and negative for CD56. Staining for neural development transcription factors (TTF1, ASCL1 and POU3F2) was positive only for POU3F2 (nuclear). Since tests using a broad battery of antibodies (CDX2, TTF1, CK7 and CK20) yielded negative results, it was not possible to identify the original tissue of the neuroendocrine component.

Figure 1.

(A) Solid islets and cell clusters separated by a fibrous stroma. Cells display eosinophilic cytoplasm, rounded nuclei and fine granular chromatin. Metastatic lesion: Mature glandular tissue staining positive for CDX2 (B) and CK7 (C). (D) Tumor cells staining positive for chromogranin-A.


The final pathological diagnosis was atypical carcinoid tumor in a metastatic mature cystic teratoma. Surgical margins were tumor free, and postoperative recovery was good, with no complications.

Two histogenetic hypotheses have been put forward to account for this association. The first is that cisplatin therapy selectively excludes immature components, whilst chemotherapy-resistant mature components survive and in some cases grow. The second is that chemotherapy induces the transformation of immature malignant teratoma into mature teratoma, a phenomenon first reported by DiSaia et al. in ovarian GCTs, and termed chemotherapeutic retroconversion.3

Somatic-type malignancy occurs in 3–6% of GCTs, almost always in postpubertal patients (aged 15–68).1,2,4 Although most affected patients have teratomatous GCTs,1,2,5 somatic-type malignancy has occasionally been reported in other germ-cell tumors including yolk-sac and spermatocytic tumors.6 The time elapsing between GTC diagnosis and the appearance of STMs tends to vary widely, ranging from simultaneous presentation to a latency period of up to 30 years. The interval for carcinomas (108 months) is longer than for sarcomas (20 months).5

Reported STMs include various types of sarcoma, epithelial malignancies and hematological malignancies.7 Sarcomas are undoubtedly the most common type of malignancy; although rhabdomyosarcomas account for over half the STMs recorded, leiomyosarcomas, angiosarcomas and other STMs have occasionally been reported.8,9 Carcinomas tend to be mostly to be classed as adenocarcinomas NOS6; there are very few reports of neuroendocrine tumors, particularly in testicular lesions.

Generally speaking, the prognosis for these tumors is not affected when the STM is located in the testicle; however, development of STM in metastases—as in the present case—is associated with an increased risk of mortality.8

The role of chemotherapy in teratomas with malignant neuroendocrine transformation has not been fully established.7 Complete surgical resection has traditionally been the treatment of choice when malignant transformation occurs at a single site. Metastatic or unresectable tumors will generally require multimodal management including chemotherapy in addition to loco-regional approaches. Although patients tend to respond poorly to cisplatin-based treatments, some tumors may respond to the specific chemotherapy used for the somatic counterpart.10

Summarizing, in this rare case a patient with mixed germ-cell tumor of the testis and metastasis, treated with chemotherapy, seven years later developed an atypical carcinoid tumor, with a somatic-like malignant component, in a metastatic mature cystic teratoma of the lung. Comprehensive pathological examination is essential for the identification of somatic neoplasms within germ cell tumor metastases.

T.M. Ulbright, M.B. Amin, B. Balzer, D.M. Berney, J.I. Epstein, C. Guo, et al.
Germ cell tumours.
WHO classification of tumours of the urinary system and male genital organs, 4th ed., pp. 189-226
M. Colecchia, A. Necchi, B. Paolini, N. Nicolai, R. Salvioni.
Teratoma with somatic-type malignant components in germ cell tumors of the testis: a clinicopathologic analysis of 40 cases with outcome correlation.
Int J Surg Pathol, 19 (2011), pp. 321-327
P.J. DiSaia, A. Saltz, A.R. Kagan, C.P. Morrow.
Chemotherapeutic retroconversion of immature teratoma of the ovary.
Obstet Gynecol, 49 (1977), pp. 346-350
T. Ahmed, G.J. Bosl, S.I. Hajdu.
Teratoma with malignant transformation in germ cell tumors in men.
Cancer, 56 (1985), pp. 860-863
K.R. Rice, M.J. Magers, S.D. Beck, K.C. Cary, L.H. Einhorn, T.M. Ulbright, et al.
Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes.
J Urol, 192 (2014), pp. 1403-1409
M.J. Magers, C.S. Kao, C.D. Cole, K.R. Rice, R.S. Foster, L.H. Einhorn, et al.
“Somatic-type” malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Am J Surg Pathol, 38 (2014), pp. 1396-1409
S.Y. Lee, Y.M. Jo, J. Lee, S.I. Cha, T.I. Park, C.H. Kim.
Neuroendocrine carcinoma arising in a mediastinal teratoma with pulmonary metastasis: a case report and the chemotherapy response.
Intern Med, 54 (2015), pp. 1277-1280
C.C. Guo, M. Punar, A.L. Contreras, S.M. Tu, L. Pisters, P. Tamboli, et al.
Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.
Am J Surg Pathol, 33 (2009), pp. 1173-1178
H.D. Malagón, A.M. Valdez, C.A. Moran, S. Suster.
Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Am J Surg Pathol, 31 (2007), pp. 1356-1362
A.C. Donadio, R.J. Motzer, D.F. Bajorin, P.W. Kantoff, J. Sheinfeld, J. Houldsworth, et al.
Chemotherapy for teratoma with malignant transformation.
J Clin Oncol, 21 (2003), pp. 4285-4291
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.